MTFB News and Press, Motif Bio plc From 05/01/19

NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has signed an agreement with Lamellar Biomedical Limited (Lamellar) under which Motif Bio wi...

NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc ("Motif Bio" or the "Company") (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that its notice of its Annual General Meeting (AGM) have been posted to shar...

Rexahn Pharmaceuticals (NYSEMKT: RNN ) +69%  on RX-3117 collaboration in China. More news on: Rexahn Pharmaceuticals, Inc., ReWalk Robotics Ltd., Motif Bio plc, Stocks on the move, Read more ...

Motif Bio (NASDAQ: MTFB ) reports new iclaprim data at the 28 th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, The Netherlands. More news on: Motif Bio plc, Motif Bio plc, Healthcare stocks news, Stocks on the move, Read more ...

NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that new iclaprim data are being presented at the 28 th European Congress of Clinical Microbiology and Inf...

Motif Bio (NASDAQ: MTFB ): FY GAAP EPS of -$0.07. More news on: Motif Bio plc, Earnings news and commentary, Healthcare stocks news, , Read more ...

NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced financial results for the year ended December 31, 2018. Dr. Graham Lumsden, Chief Executive Officer, sai...

WASHINGTON , April 12, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug-resistant infections and spur life-saving innovations, today announced that twelve of its member companies will present data from their clinica...

China Bat (NASDAQ: GLG ) +45%  on entering into a strategic cooperation agreement with Liten Group. More news on: China Bat Group, Inc., Papa Murphy's Holdings, Inc., Hancock Jaffe Laboratories, Inc., Stocks on the move, Read more ...

Shineco (NASDAQ: TYHT ) +39% . More news on: Shineco, Inc., Recro Pharma, Inc., Tonix Pharmaceuticals Holding Corp., Stocks on the move, Read more ...